Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Robert H. Berndsen, Andrea Weiss, U. Kulsoom Abdul, Tse J. Wong, Patrick Meraldi, Arjan W. Griffioen, Paul J. Dyson, Patrycja Nowak-Sliwinska

Journal title: Scientific Reports

Journal number: 7/1

Journal publisher: Nature Publishing Group

Published year: 2017

DOI identifier: 10.1038/srep43005

ISSN: 2045-2322